Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
Chengcheng Yang(First Affiliated Hospital of Xi'an Jiaotong University), Sarat Chandarlapaty(Memorial Sloan Kettering Cancer Center)
Cited by 430
Related Papers
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
|Oncogene|2018|149
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
|Nature Communications|2021|86
CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
|International Journal of Oncology|2019|76
Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis
|Journal of Clinical Investigation|2020|45